What's Happening?
Venture Medical, LLC has issued a statement regarding the Centers for Medicare & Medicaid Services (CMS) Calendar Year 2026 Physician Fee Schedule (PFS) Final Rule. This new framework introduces changes
to the Medicare reimbursement for skin substitutes, which Venture Medical believes will significantly impact the wound care industry. John Schroeder, CEO of Venture Medical, expressed concerns that the $127 PFS rate could compromise access to therapies and specialized wound care. The company is committed to working with industry colleagues, CMS, policymakers, and key opinion leaders to improve reimbursement and access to skin substitutes. Venture Medical aims to lead with preparation and confidence, offering education, policy guidance, and product solutions to help customers navigate these updates.
Why It's Important?
The CMS 2026 Physician Fee Schedule Final Rule represents a significant shift in the reimbursement structure for skin substitutes, which could affect patient access to advanced wound care therapies. Venture Medical's response highlights the potential challenges faced by providers in delivering outcomes-driven care under the new rate. The company's proactive approach to advocacy and innovation is crucial in ensuring that clinicians can continue to provide high-quality patient care while maintaining operational excellence. The changes could have broader implications for the wound care industry, influencing how providers manage clinical and economic demands.
What's Next?
Venture Medical plans to accelerate its efforts in collaboration with industry partners and policymakers to address the challenges posed by the new CMS framework. The company is focused on improving reimbursement and access to skin substitutes, aiming to alleviate threats to patient care. As the market transitions to this new era of standardized reimbursement, Venture Medical remains committed to advocacy, innovation, and partnership, helping clinicians deliver the highest level of patient care.
Beyond the Headlines
The CMS 2026 Physician Fee Schedule Final Rule could lead to long-term shifts in the wound care industry, emphasizing the need for evidence-based practices and quality compliance. Venture Medical's commitment to advocacy and innovation may set a precedent for other companies in the industry, potentially influencing future policy decisions and reimbursement structures.
